A 14-year-old girl with a history of retinoblastoma (treated with chemotherapy and radiation 8 years ago) presents with progressive pain and swelling of the proximal humerus over the past 4 months. Radiographs show a mixed lytic and sclerotic lesion with cortical destruction and soft tissue mass. She undergoes staging investigations: chest CT shows multiple pulmonary nodules, and alkaline phosphatase is 580 U/L. Biopsy confirms osteosarcoma. Which of the following is the most important prognostic factor in this case?

Explanation

## Prognostic Factors in Osteosarcoma ### Primary Prognostic Determinant **High-Yield:** The presence of metastatic disease at diagnosis is the single most important prognostic factor in osteosarcoma. Patients with metastases at presentation have a 5-year survival of ~20%, compared to ~70% for localized disease. ### Prognostic Factors Hierarchy | Factor | Impact on Prognosis | Evidence | |--------|-------------------|----------| | **Metastatic disease** | Most critical | 5-yr survival: 20% (metastatic) vs 70% (localized) | | **Chemotherapy response** | Very important | Good response (>90% necrosis) → 80% survival; poor response → 40% survival | | **Surgical margins** | Important | Wide negative margins essential for local control | | **Tumor size** | Moderate | Size > 8 cm associated with worse prognosis but not independent of metastases | | **Alkaline phosphatase** | Moderate | Elevated levels correlate with tumor burden but not independent predictor | | **Location** | Minor | Distal femur/proximal tibia slightly better than pelvic/axial | ### Metastatic Pattern in Osteosarcoma **Key Point:** Osteosarcoma has a propensity for early hematogenous spread, particularly to the lungs (85% of metastases). At presentation, 15–20% of patients have clinically detectable metastases; however, micrometastases are present in ~80% of patients at diagnosis. ### Clinical Pearl: Secondary Osteosarcoma This patient has a **secondary osteosarcoma** arising in the field of prior radiation therapy for retinoblastoma. Secondary osteosarcomas: - Occur in 5–10% of retinoblastoma survivors - Develop 5–25 years post-radiation - Have a worse prognosis than primary osteosarcoma (5-yr survival ~30%) - Often present at advanced stage with metastases ### Treatment Implications **High-Yield:** Even with metastatic disease, multimodal therapy (neoadjuvant chemotherapy, surgical resection of primary and resectable metastases, adjuvant chemotherapy) can achieve cure in select cases. Pulmonary nodulectomy for resectable lung metastases is standard of care. **Mnemonic: MAPS** — **M**etastases (most important), **A**lkaline phosphatase (moderate), **P**rimary site (minor), **S**urgical margins (critical for local control).